Innospec Inc. (IOSP) SEC Filings & Earnings Calls
EquiReason read 10 Innospec Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-05 — Total revenues $491M (+12% y/y); Net income attributable to Innospec $31M (+31% y/y); GAAP EPS $1.25 (+33% y/y).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 2.4B
- P/E TTM
- 20.1
- Dividend yield
- 1.8%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
5 Aug 20268-K · 2.02Total revenues $491M (+12% y/y); Net income attributable to Innospec $31M (+31% y/y); GAAP EPS $1.25 (+33% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $491M | +12% y/y |
| Net income attributable to Innospec · Q2-2026 | $31M | +31% y/y |
| GAAP EPS · Q2-2026 | $1.25 | +33% y/y |
| Adjusted EPS · Q2-2026 | $1.27 | +1% y/y |
| Adjusted EBITDA · Q2-2026 | $50M | +2% y/y |
| Operating cash flow · Q2-2026 | $7M | -31% y/y |
| Capital expenditures · Q2-2026 | $17M | |
| Net cash · Q2-2026 | $250M |
Risks flagged
Operating cash flow declined 31% YoY to $7.2M, though expected to improve in H2 with working capital efficiency.
“Cash from operating activities was $7.2 million compared to $10.5 million a year ago.” · word for word
5 Aug 202610-QInnospec reported Q2 2026 net sales of $491.4M (+12% YoY), net income of $30.8M (+31% YoY), and diluted EPS of $1.25 (+33% YoY).earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $491M | +12% y/y |
| Gross profit · Q2-2026 | $138M | +12% y/y |
| Operating income · Q2-2026 | $40M | +16% y/y |
| Net income attributable to Innospec · Q2-2026 | $31M | +31% y/y |
| Diluted earnings per share · Q2-2026 | $1.25 | +33% y/y |
| Performance Chemicals net sales · Performance Chemicals · Q2-2026 | $190M | +9% y/y |
| Fuel Specialties net sales · Fuel Specialties · Q2-2026 | $186M | +12% y/y |
| Oilfield Services net sales · Oilfield Services · Q2-2026 | $115M | +14% y/y |
| Performance Chemicals gross margin · Performance Chemicals · Q2-2026 | 17.3% | |
| Fuel Specialties gross margin · Fuel Specialties · Q2-2026 | 36.6% |
Risks flagged
Supply chain disruption
“Americas volumes were lower due to some supply constraints and reduced demand for our personal care products” · word for word
Demand weakness in personal care
“Americas volumes were lower due to some supply constraints and reduced demand for our personal care products” · word for word
Adverse sales mix in Fuel Specialties
“Gross margin: the year over year decrease of 1.5 percentage points was due to an adverse sales mix in the Americas from increased sales of lower margin products” · word for word
Severe weather impact on production
“negative manufacturing variances due to lower production volumes in North America, as we continue to advance our plant repairs, process improvements and upgrades following severe weather conditions in the first quarter”
8 May 202610-QNet sales $453M (+3% y/y); Net income attributable to Innospec $30M (-7% y/y); Operating cash flow $18M (-38% y/y)open
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $453M | +3% y/y |
| Net income attributable to Innospec · Q1-2026 | $30M | -7% y/y |
| Operating cash flow · Q1-2026 | $18M | -38% y/y |
| Performance Chemicals net sales · Performance Chemicals · Q1-2026 | $169M | +1% y/y |
| Fuel Specialties net sales · Fuel Specialties · Q1-2026 | $182M | +7% y/y |
| Oilfield Services net sales · Oilfield Services · Q1-2026 | $102M | +0% y/y |
Risks flagged
Performance Chemicals margin pressure
“Performance Chemicals gross margin decreased 4.2 percentage points year-over-year due to adverse sales mix and negative manufacturing variances.”
Corporate cost increase
“Corporate costs increased $4.6 million, or 26%, year-over-year due to higher legacy costs, legal expenses, and ERP amortization.”
8 May 20268-K · 2.02, 7.01Semi-annual cash dividend per share $0.92; Share repurchase authorization $75M (+50% y/y)earningsopen
Figures in the filing · each found in the filing text
| Semi-annual cash dividend per share · 2026 | $0.92 | |
| Share repurchase authorization · 2026 | $75M | +50% y/y |
Risks flagged
No material risk signals; routine capital allocation decisions.
“No risk factors disclosed.”
26 Mar 2026DEF 14AAnnual proxy statement filed detailing executive compensation structure, governance practices, and shareholder proposals.open
Figures in the filing · each found in the filing text
| Net Cash · FY2025 | $293M | |
| Dividend per share · FY2025 | $1.71 | +10% y/y |
| Corporate Operating Income (before nonrecurring items) · FY2025 | $152M | |
| Corporate Free Cash Flow (before nonrecurring items) · FY2025 | $65M | |
| Revenue Growth (Performance Chemicals) · Performance Chemicals · FY2025 | 4.0% | |
| CEO Total Compensation · FY2025 | $8M | |
| CEO Base Salary · FY2025 | $1M | 0% y/y |
| CEO MICP Bonus · FY2025 | $1M | |
| CEO Target Bonus % of Salary · FY2025 | 120.0% | |
| CEO Maximum Bonus % of Salary · FY2025 | 276.0% |
Risks flagged
Global economic and geopolitical headwinds impacting financial results
“The past year presented significant challenges for the company, as global economic pressures, geopolitical instability, and industry-specific headwinds impacted our financial results.” · word for word
Underperformance in certain business segments requiring corrective actions
“Took direct, hands-on leadership to address underperformance in relevant business segments, implementing organizational changes, margin improvement actions, and strengthened accountability.” · word for word
M&A integration risk (QGP acquisition issues)
“led major corrective actions at QGP, including a $7M intangible write-down and FX hedge reset” · word for word
18 Feb 202610-KRevenue $1.78B (-4% y/y); Net Income $117M (+228% y/y); Operating Cash Flow $138M (-25% y/y)open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $1.78B | -4% y/y |
| Net Income · FY2025 | $117M | +228% y/y |
| Operating Cash Flow · FY2025 | $138M | -25% y/y |
| Performance Chemicals Revenue · Performance Chemicals · FY2025 | $681M | +4% y/y |
| Fuel Specialties Revenue · Fuel Specialties · FY2025 | $702M | +0% y/y |
| Oilfield Services Revenue · Oilfield Services · FY2025 | $395M | -20% y/y |
| Performance Chemicals Gross Margin · Performance Chemicals · FY2025 | 17.9% | |
| Fuel Specialties Gross Margin · Fuel Specialties · FY2025 | 36.0% | |
| Oilfield Services Gross Margin · Oilfield Services · FY2025 | 29.9% | |
| Cash and Cash Equivalents · 2025-12-31 | $293M | +1% y/y |
Guidance
Management expects margin improvement actions to drive growth in Performance Chemicals and Oilfield Services in 2026; Fuel Specialties expected to remain consistent. No numerical guidance provided.
Risks flagged
Oilfield Services Demand Decline
“Oilfield Services... revenues were down 19 percent on the prior year, and operating income decreased 40 percent driven by no recovery in our Latin American business and lower than expected Middle East and US completion activity in the second half of 2025.”
Performance Chemicals Margin Pressure
“Performance Chemicals... Gross margin... -4.8... primarily due to pricing erosion and higher demand for our lower margin products.”
Impairment Risk
“Impairment of property, plant and equipment $22.9... Impairment of intangible assets $19.1”
18 Feb 20268-K · 2.02Total revenues $456M (-2% y/y); Net income $47M; GAAP EPS $1.91earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q4-2025 | $456M | -2% y/y |
| Net income · Q4-2025 | $47M | |
| GAAP EPS · Q4-2025 | $1.91 | |
| Adjusted non-GAAP EPS · Q4-2025 | $1.50 | +6% y/y |
| Adjusted EBITDA · Q4-2025 | $56M | -2% y/y |
| Operating cash flow · Q4-2025 | $61M | |
| Capital expenditures · Q4-2025 | $21M | |
| Net cash · FY2025 | $293M | |
| Fuel Specialties revenue · Fuel Specialties · Q4-2025 | $194M | +1% y/y |
| Fuel Specialties operating income · Fuel Specialties · Q4-2025 | $37M | +7% y/y |
Risks flagged
Oilfield Services revenue decline due to reduced US completions and Middle East activity.
“Oilfield Services revenues down 12% on reduced activity in US completions and in the Middle East.”
Performance Chemicals gross margin contraction of 4.6pp year-over-year.
“Gross margins of 18.1% decreased by 4.6 percentage points from the same quarter last year.”
5 Nov 20258-K · 2.02, 7.01Total revenues $442M (+0% y/y); Net income $13M (-61% y/y); Adjusted non-GAAP EPS $1.12 (-17% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $442M | 0% y/y |
| Net income · Q3-2025 | $13M | -61% y/y |
| Adjusted non-GAAP EPS · Q3-2025 | $1.12 | -17% y/y |
| Adjusted EBITDA · Q3-2025 | $44M | -12% y/y |
| Cash from operating activities · Q3-2025 | $39M | -47% y/y |
| Net cash · Q3-2025 | $271M | |
| Performance Chemicals revenue · Performance Chemicals · Q3-2025 | $171M | +4% y/y |
| Fuel Specialties revenue · Fuel Specialties · Q3-2025 | $172M | +4% y/y |
| Oilfield Services revenue · Oilfield Services · Q3-2025 | $99M | -13% y/y |
| Capital expenditures · Q3-2025 | $22M |
Risks flagged
Impairments and restructuring charges of $42.9M in QGP and US stimulation businesses.
“$42.9 million of asset and intangible impairments and restructuring charges related to the expected lack of near-term recovery in QGP, our Mexican oilfield production business and our US stimulation business.” · word for word
Performance Chemicals gross margins declined 7ppt; operating income down 54%.
“Gross margins of 15.1% decreased by 7.0 percentage points; operating income of $9.2 million decreased 54%.”
Oilfield Services revenue down 13%; operating income down 32%.
“Revenues in Oilfield Services of $99.1 million were down 13%; operating income of $4.8 million decreased 32%.” · word for word
5 Nov 202510-QInnospec reported Q3 2025 net income of $12.9M, down 61% YoY, with significant impairments in Oilfield Services and Performance Chemicals margin pressure.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $442M | -0% y/y |
| Net income · Q3-2025 | $13M | -61% y/y |
| Diluted EPS (GAAP) · Q3-2025 | $0.52 | -61% y/y |
| Performance Chemicals net sales · Performance Chemicals · Q3-2025 | $171M | +4% y/y |
| Fuel Specialties net sales · Fuel Specialties · Q3-2025 | $172M | +4% y/y |
| Oilfield Services net sales · Oilfield Services · Q3-2025 | $99M | -13% y/y |
| Operating cash flow · 9M-2025 | $77M | -52% y/y |
Risks flagged
Oilfield Services demand weakness
“Oilfield Services net sales have decreased year over year by $82.8 million, or 22 percent, with the majority of our customer activity concentrated in the Americas region.” · word for word
Asset impairment risk
“During the quarter ended September 30, 2025, the Company impaired property, plant and equipment assets within its Oilfield Services segment. The impaired assets totaled $22.9 million... impaired the intangible assets... totaled $19.1 million.” · word for word
Pricing erosion in Performance Chemicals
“Gross margin: the year over year decrease of 7.0 percentage points was primarily due to pricing erosion, higher demand for our lower priced products and the impact of some tariffs not passed on to customers.” · word for word
Innospec Inc. — questions
- What did Innospec Inc. file recently?
- 10 SEC filings in the last 12 months. Latest: 8-K on 2026-08-05 — Total revenues $491M (+12% y/y); Net income attributable to Innospec $31M (+31% y/y); GAAP EPS $1.25 (+33% y/y)
Every figure on this page comes from Innospec Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.